AELIS FARMA
LIVE

Serial Number

79429785

Owner

AELIS FARMA

Attorney

Emily Haas

Filing Date

Feb 6, 2025

Add to watchlist:

No watchlists yet
View on USPTO

AELIS FARMA Trademark

Serial Number: 79429785

AELIS FARMA is a trademark filed by AELIS FARMA on February 6, 2025. The trademark is classified under Class 42 (Computer & Scientific), Class 45 (Legal & Security Services). The application is currently pending registration.

Owner Contact Info

AELIS FARMA (2 trademarks)

1 Rue Lafaurie de Monbadon

Entity Type: 98

Trademark Details

Filing Date

February 6, 2025

Registration Date

Not Registered

Published for Opposition

August 11, 2026

Goods & Services

Licensing services regarding intellectual property rights in the pharmaceutical, medical, pharmacological, biological, biotechnological, biochemical, molecular and clinical fields; intellectual property licensing services for research and development in pharmaceutical, medical, pharmacological, biological, biotechnological, biochemical, molecular and clinical fields

Evaluations and assessments of the goods of others in the scientific, pharmaceutical, pharmacological, biological, biotechnological, biochemical and clinical fields to assure compliance with industry standards, therapeutic efficiency, and patient tolerability; research and development in the pharmaceutical, medical, pharmacological, biological, biotechnological, biochemical and clinical fields; pre-clinical and clinical research in the field of neurology, psychiatry, dermatology, addictology, and pathology; pre-clinical and clinical research in the field of behavioral disorder treatment, cognitive disorder treatment, and metabolic syndrome treatment; preclinical and clinical research in the field of endocannabinoid system-dependent diseases; conducting clinical trials for others related to pharmaceuticals; scientific research for medical purposes in the field of neurology, psychiatry, dermatology, addictology, and pathology; scientific research for medical purposes in the field of behavioral disorder treatment, cognitive disorder treatment, and metabolic syndrome treatment; scientific research for medical purposes in the field of endocannabinoid system-dependent diseases; design, testing and development of molecules and new molecular entities for therapeutic purposes; scientific laboratory services; chemical and biochemical analyses; providing scientific analyses related to pharmaceutical and medicated preparation design; testing of new pharmaceutical products for third parties; provision of information related to scientific research in pharmaceutical, medical, pharmacological, biological, biotechnological, biochemical and clinical fields; providing and making available scientific information to third parties in the field of clinical and pre-clinical trials; providing information to third parties concerning results of clinical trials for medical and pharmaceutical products

Filing History

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 5, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 15, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 15, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 15, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 15, 2026 TROA
REFUSAL PROCESSED BY IB
Mar 19, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 27, 2026 RFCS
REFUSAL PROCESSED BY MPU
Feb 27, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 31, 2026 RFCR
NON-FINAL ACTION WRITTEN
Jan 30, 2026 CNRT
ASSIGNED TO EXAMINER
Jan 30, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 29, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 29, 2026 NWOS
NEW REPRESENTATIVE AT IB RECEIVED
Jan 29, 2026 NREP
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Sep 13, 2025 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 7, 2025 REPR